Group One Trading, L.P. Celldex Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$32.76 - $42.56 $19,623 - $25,493	-599 Reduced 6.4%	8,757 $324,000
Q1 2024 May 10, 2024	SELL	$35.22 - $51.88 $428,979 - $631,898	-12,180 Reduced 56.56%	9,356 $392,000
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $85,465 - $153,657	3,780 Added 21.29%	21,536 $854,000
Q3 2023 Nov 09, 2023	SELL	$25.45 - $37.46 $346,349 - $509,793	-13,609 Reduced 43.39%	17,756 $488,000
Q2 2023 Aug 09, 2023	BUY	$30.29 - $38.28 $340,489 - $430,305	11,241 Added 55.86%	31,365 $1.06 Million
Q1 2023 May 12, 2023	BUY	$34.78 - $47.43 $456,174 - $622,091	13,116 Added 187.16%	20,124 $724,000
Q4 2022 Feb 09, 2023	SELL	$27.78 - $45.38 $188,376 - $307,721	-6,781 Reduced 49.18%	7,008 $312,000
Q3 2022 Nov 09, 2022	SELL	$22.7 - $37.57 $329,853 - $545,929	-14,531 Reduced 51.31%	13,789 $388,000
Q2 2022 Aug 11, 2022	BUY	$20.5 - $37.33 $175,152 - $318,947	8,544 Added 43.2%	28,320 $764,000
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $702,940 - $999,986	-25,432 Reduced 56.26%	19,776 $674,000
Q4 2021 Feb 11, 2022	BUY	$35.68 - $56.27 $640,705 - $1.01 Million	17,957 Added 65.89%	45,208 $1.75 Million
Q3 2021 Nov 12, 2021	BUY	$28.95 - $55.99 $28,023 - $54,198	968 Added 3.68%	27,251 $1.47 Million
Q2 2021 Aug 10, 2021	SELL	$20.71 - $35.37 $1.17 Million - $1.99 Million	-56,354 Reduced 68.19%	26,283 $879,000
Q1 2021 May 12, 2021	BUY	$16.19 - $29.91 $946,758 - $1.75 Million	58,478 Added 242.05%	82,637 $1.7 Million
Q4 2020 Feb 10, 2021	BUY	$14.99 - $22.75 $362,143 - $549,617	24,159 New	24,159 $423,000
Q2 2020 Aug 13, 2020	SELL	$1.61 - $13.41 $16,204 - $134,971	-10,065 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$1.55 - $3.07 $1,247 - $2,471	-805 Reduced 7.41%	10,065 $17,000
Q4 2019 Feb 10, 2020	SELL	$2.11 - $2.8 $14,700 - $19,507	-6,967 Reduced 39.06%	10,870 $24,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.75 $22,344 - $29,975	10,900 Added 157.13%	17,837 $38,000
Q2 2019 Aug 09, 2019	SELL	$2.43 - $5.09 $9,746 - $20,415	-4,011 Reduced 36.64%	6,937 $19,000
Q1 2019 May 13, 2019	BUY	$3.45 - $10.35 $37,770 - $113,311	10,948 New	10,948 $54,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

Wellington Management Group LLP Boston, MA

9.24M
Shares

$244 Million
0.06% of portfolio
Black Rock Inc. New York, NY

4.69M
Shares

$124 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.87M
Shares

$102 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

3.46M
Shares

$91.3 Million
9.64% of portfolio
Eventide Asset Management, LLC Boston, MA

3.33M
Shares

$88 Million
1.99% of portfolio

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account